Last reviewed · How we verify
Calcium carbonate tablets — Competitive Intelligence Brief
marketed
Mineral supplement / Calcium salt
Rheumatology / Bone Health / Nutritional Supplementation
Small molecule
Live · refreshed every 30 min
Target snapshot
Calcium carbonate tablets (Calcium carbonate tablets) — Chinese SLE Treatment And Research Group. Calcium carbonate provides supplemental calcium ions to correct hypocalcemia and support bone mineralization.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Calcium carbonate tablets TARGET | Calcium carbonate tablets | Chinese SLE Treatment And Research Group | marketed | Mineral supplement / Calcium salt |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Mineral supplement / Calcium salt class)
- Chinese SLE Treatment And Research Group · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Calcium carbonate tablets CI watch — RSS
- Calcium carbonate tablets CI watch — Atom
- Calcium carbonate tablets CI watch — JSON
- Calcium carbonate tablets alone — RSS
- Whole Mineral supplement / Calcium salt class — RSS
Cite this brief
Drug Landscape (2026). Calcium carbonate tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/calcium-carbonate-tablets. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing